产品名称：Human BDCA-2 Antibody (BIIB059, Research Use)
产品编号：NBR-0006
针对靶点：BDCA-2
抗体药商品名：BIIB059
抗体药描述：BIIB059, discovered and developed exclusively by Biogen, is a humanized IgG1 monoclonal antibody (mAb) targeting blood dendritic cell antigen 2 (BDCA2) and is being investigated for the potential treatment of systemic lupus erythematosus (SLE) and cutaneous lupus erythematosus (CLE) 产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

  Gene Name: BDCA-2
Synonyms: CLEC4C; CD303; CLECSF11; CLECSF7; DLEC; HECL
Target Description: CLEC4C (C-Type Lectin Domain Family 4 Member C) is a Protein Coding gene. Diseases associated with CLEC4C include Cutaneous Lupus Erythematosus and Cardiomyopathy, Dilated, 1C, With Or Without Left Ventricular Noncompaction. Among its related pathways are Innate Immune System and CLEC7A (Dectin-1) signaling. Gene Ontology (GO) annotations related to this gene include carbohydrate binding. An important paralog of this gene is CLEC6A.
Ensembl: ENSG00000198178
Uniprot: Q8WTT0